SCHEMBL5580549

SCHEMBL5580549

COc1ccc(CC(=O)O)cc1-c1cccc(OCC=Cc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.48
PTGES O14684 1/20 0.48
ALOX5 P09917 1/20 0.48
PPARG P37231 1/20 0.48
PTGDR2 Q9Y5Y4 13/20 0.45
TBXA2R P21731 3/20 0.45
PTGDR Q13258 3/20 0.45
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
PTGIR P43119 1/20 0.43
CTSA P10619 1/20 0.42
CASR P41180 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5580545 1.00 PSEN1 (0.48) PSEN1PTGESALOX5PPARGPTGDR2
SCHEMBL5580791 0.88 PSEN1 (0.47) PSEN1PTGESALOX5PPARGPSEN2
SCHEMBL5580731 0.88 PSEN1 (0.47) PSEN1PTGESALOX5PPARGPSEN2
SCHEMBL5580784 0.88 PSEN1 (0.47) PSEN1PTGESALOX5PPARGPSEN2
SCHEMBL5580734 0.88 PSEN1 (0.47) PSEN1PTGESALOX5PPARGPSEN2
SCHEMBL5580737 0.88 PPARD (0.41) PSEN1PTGESALOX5PPARGPTGDR2
SCHEMBL5580733 0.88 PPARD (0.41) PSEN1PTGESALOX5PPARGPTGDR2
SCHEMBL3508227 0.86 PPARG (0.49) PSEN1PTGESALOX5PPARGPTGDR2
SCHEMBL3508229 0.86 PPARG (0.49) PSEN1PTGESALOX5PPARGPTGDR2
SCHEMBL5580428 0.86 RXRA (0.46) PSEN1PTGESALOX5PPARGPSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US claimed
EP-1604971-A1 CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 EP claimed
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
EP-1604971-A1 CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient LPL, GPR119, EBP PSEN1 3648/4885PTGES 783/4885ALOX5 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.